We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Therapies Designed to Restore Damaged Cartilage Are Ineffectual HST

By HospiMedica International staff writers
Posted on 27 Jul 2016
The collagen matrix of human articular cartilage is an essentially permanent structure that has no significant turnover in adults, according to a new study.

Researchers at the University of Copenhagen (KU, Denmark), Aarhus University (Denmark), and other institutions used the carbon-14 (C14) bomb-pulse dating method to measure life-long replacement rates of collagen in tibial plateau cartilage from 23 people aged 18 to 76 years of age, who underwent knee replacement surgery; 15 of the participants suffered from osteoarthritis (OA), and 8 had healthy cartilage. More...
Since the study's goal was to assess collagen turnover, other substances were filtered out of the samples.

C14 results revealed that virtually no replacement of the collagen matrix happened after reaching skeletal maturity, and neither OA nor tissue damage influenced collagen turnover. Regional C14 differences across the joint surface showed that cartilage collagen located centrally formed several years earlier than the collagen located peripherally. However, when the researchers examined the filtrates removed from the collagen matrix, they found that collaglycos-aminoglycans (GAGs) had a much faster turnover rate, making them a potential therapeutic target in the treatment of OA. The study was published on July 6, 2016, in Science Translational Medicine.

“This finding has important implications for the tissue engineering and regenerative medicine fields, where the structural permanence of collagen will need to be contemplated when designing new cartilage repair strategies”, concluded lead author Katja Heinemeier, PhD, of KU, and colleagues. “OA research should aim at overall prevention, and/or therapeutic techniques that target GAGs, or other substances with quick turnover rates when compared with collagen.”

“Optimally, we should prevent injuries from childhood and teenage years and possibly also examine whether we are prone to cartilage injuries later in life. However, once the damage is done, you can, by way of gentle exercise, train other molecules in the cartilage to absorb fluids, which in turn will increase the remaining cartilage’s elasticity and shock absorption,” concluded senior author Professor Michael Kjær, MD, of KU. “Generally speaking though, we should stay active throughout life and avoid too much wear and tear in our joints.”

Cartilage structures and functions can be damaged due to a variety of causes, such as a bad fall or traumatic sport-accident, previous knee injuries, or wear and tear over time. Articular cartilage does not usually regenerate after injury or disease, leading to loss of tissue and formation of a defect. Collagen (which is Latin for glue), in turn, is the main structural protein of connective tissue, and is the most abundant protein in mammals, making up 25-35% of the whole-body protein content.

Related Links:
University of Copenhagen
Aarhus University

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.